O&G · Postpartum care — lactation
Lactation: establishment, complications, suppression and drug safety
Also known as Breastfeeding · Mastitis · Lactational breast abscess · Lactation suppression · Engorgement · Galactagogues · Drugs in breastfeeding
Exam-exhaustive FRANZCOG fellowship reference on lactation — secretory activation and the prolactin and oxytocin reflexes, attachment and nipple damage, the mastitis spectrum with antibiotic doses and the four practices the 2022 protocol reversed, abscess drainage, low supply and galactagogues, cabergoline suppression, and how to answer a drug-safety question using the resources actually used in Australia and New Zealand.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- A red breast that has not settled in 48 hours of correct treatment — image it, do not simply change the antibiotic
- Mastitis that never fully resolves — inflammatory breast cancer hides behind a non-resolving red breast
- Sepsis in a breastfeeding woman — the breast is a source, and she needs antibiotics inside the hour
- An infant losing more than 10 per cent of birth weight or with fewer than 6 wet nappies a day — feeding failure, not a feeding preference
- Bromocriptine for suppression — replaced by cabergoline because of serious cardiovascular and psychiatric adverse events
- Telling a woman a drug is unsafe in breastfeeding without checking a real source — most are compatible
Day 4, and the woman in bed 6 is crying before you reach her. Her nipples are cracked, her breasts are rock hard, the baby has lost 9 per cent of its birth weight and somebody has already suggested formula. Every single one of those problems is fixable in the next twenty minutes if you know what you are looking at. Lactation is not a "midwifery issue" you can defer — it is examinable, it is where women are failed, and it turns up in the oral as a communication station.[2][1]
Overview and definition
Milk-making happens in three named phases, and knowing them tells you which problem you are solving. [1][17]
- Lactogenesis I — secretory differentiation in the second half of pregnancy. The gland is built and colostrum is present before birth.[1]
- Secretory activation (lactogenesis II) — the "milk coming in" at roughly 30 to 72 hours after birth, triggered by progesterone withdrawal once the placenta is delivered. Delayed secretory activation means it has not happened by 72 hours.[1][17]
- Galactopoiesis — maintenance. From this point supply follows demand, governed locally rather than centrally.[1]
References19ShowHide
- [1]Mitchell KB, Johnson HM, Rodríguez JM, et al. Academy of Breastfeeding Medicine Clinical Protocol #36: The Mastitis Spectrum, Revised 2022 Breastfeed Med, 2022.PMID 35576513
- [2]Victora CG, Bahl R, Barros AJ, et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect Lancet, 2016.PMID 26869575
- [3]Jahanfar S, Ng CJ, Teng CL Antibiotics for mastitis in breastfeeding women Cochrane Database Syst Rev, 2013.PMID 23450563
- [4]Irusen H, Rohwer AC, Steyn DW, Young T Treatments for breast abscesses in breastfeeding women Cochrane Database Syst Rev, 2015.PMID 26279276
- [5]Zakarija-Grkovic I, Stewart F Treatments for breast engorgement during lactation Cochrane Database Syst Rev, 2020.PMID 32944940
- [6]Crepinsek MA, Taylor EA, Michener K, Stewart F Interventions for preventing mastitis after childbirth Cochrane Database Syst Rev, 2020.PMID 32987448
- [7]Forster DA, Moorhead AM, Jacobs SE, et al. Advising women with diabetes in pregnancy to express breastmilk in late pregnancy (Diabetes and Antenatal Milk Expressing [DAME]): a multicentre, unblinded, randomised controlled trial Lancet, 2017.PMID 28589894
- [8]Moore ER, Brimdyr K, Blair A, et al. Immediate or early skin-to-skin contact for mothers and their healthy newborn infants Cochrane Database Syst Rev, 2025.PMID 41120189
- [9]Hotham N, Hotham E Drugs in breastfeeding Aust Prescr, 2015.PMID 26648652
- [10]Yang Y, Boucoiran I, Tulloch KJ, Poliquin V Is Cabergoline Safe and Effective for Postpartum Lactation Inhibition? A Systematic Review Int J Womens Health, 2020.PMID 32210637
- [11]Shrateh ON, Kumar KA, Jawed A, et al. Comparing pyridoxine with dopaminergic agonists (cabergoline and bromocriptine): Unveiling the strategy for lactation inhibition - A systematic review of clinical trials J Gynecol Obstet Hum Reprod, 2024.PMID 38554942
- [12]Asztalos EV, Kiss A, daSilva OP, et al. Evaluating the Effect of a 14-Day Course of Domperidone on Breast Milk Production: A Per-Protocol Analysis from the EMPOWER Trial Breastfeed Med, 2019.PMID 30543461
- [13]Grzeskowiak LE, Smithers LG, Amir LH, Grivell RM Domperidone for increasing breast milk volume in mothers expressing breast milk for their preterm infants: a systematic review and meta-analysis BJOG, 2018.PMID 29469929
- [14]Atli N, Özkan H, Seri̇n EK Prevention and management of nipple wound: a systematic review BMC Pregnancy Childbirth, 2026.PMID 41866474
- [15]Scardina L, Di Pumpo A, Di Leone A, et al. Management of lactational and non-lactational breast abscesses: an evidence-based framework to support breast surgeon decision-making Updates Surg, 2026.PMID 42334816
- [16]Fan YW, Fan HSL, Shing JSY, et al. Impact of baby-friendly hospital initiatives on breastfeeding outcomes: Systematic review and meta-analysis Women Birth, 2025.PMID 39919651
- [17]De Bortoli J, Amir LH Is onset of lactation delayed in women with diabetes in pregnancy? A systematic review Diabet Med, 2016.PMID 26113051
- [18]Lawlor-Smith L, Lawlor-Smith C Vasospasm of the nipple--a manifestation of Raynaud's phenomenon: case reports BMJ, 1997.PMID 9066478
- [19]Grzeskowiak LE, Wlodek ME, Geddes DT What Evidence Do We Have for Pharmaceutical Galactagogues in the Treatment of Lactation Insufficiency?-A Narrative Review Nutrients, 2019.PMID 31035376